Verve Therapeutics, Inc.

Some of the best links we picked up around the internet

Eli Lilly to Acquire Verve Therapeutics to Advance...

Jun. 17, 2025

Eli Lilly announced today that it will acquire Verve Therapeutics for up to $1.3 billion to develop single-dose base-editing treatments for people...

CMN Weekly (25 April 2025) - Your Weekly CRISPR...

CMN Weekly

Apr. 25, 2025

Some of the best links we picked up around the internet

CMN Weekly (28 March 2025) - Your Weekly CRISPR...

CMN Weekly

Mar. 28, 2025

Some of the best links we picked up around the internet

CMN Weekly (8 November 2024) - Your Weekly CRISPR...

CMN Weekly

Nov. 8, 2024

Some of the best links we picked up around the internet

CMN Weekly (7 June 2024) - Your Weekly CRISPR...

CMN Weekly

Jun. 7, 2024

Some of the best links we picked up around the internet

CMN Weekly (24 May 2024) - Your Weekly CRISPR...

CMN Weekly

May. 24, 2024

Some of the best links we picked up around the internet

CMN Weekly (10 May 2024) - Your Weekly CRISPR...

CMN Weekly

May. 10, 2024

Some of the best links we picked up around the internet

Verve Therapeutics, Inc.

Refractory Hypercholesterolemia, (NCT06451770)
Sponsors:
Verve Therapeutics, Inc.

IND Enabling

Phase I

Phase II

Phase III

Familial Hypercholesterolemia, HeFH, or Premature Coronary Artery Disease, CAD, (NCT06164730)
Sponsors:
Verve Therapeutics, Inc.

IND Enabling

Phase I

Phase II

Phase III

Familial Hypercholesterolemia, FH, (NCT06112327)
Sponsors:
Verve Therapeutics, Inc.

IND Enabling

Phase I

Phase II

Phase III

Familial Hypercholesterolemia, FH, (NCT05398029)
Sponsors:
Verve Therapeutics, Inc.,

IND Enabling

Phase I

Phase II

Phase III